Zoledronic acid enhances the efficacy of immunotherapy in non-small cell lung cancer
, 2022 Yue Zheng +4 more
openalex +1 more source
Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment [PDF]
, 2021 Yuka Kameda +3 more
openalex +1 more source
Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
Clinical Interventions in Aging, 2008 Irene Lambrinoudaki, Sophia Vlachou, Fotini Galapi, Dimitra Papadimitriou, K Papadias2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, GreeceAbstract: Zoledronic acid is a nitrogen-containing, third-generation ...
Irene Lambrinoudaki +4 more
doaj
Effect of zoledronic acid and denosumab in patients with low back pain and modic change: a proof of principle trial [PDF]
, 2018 Guoqi Cai +8 more
openalex +1 more source
Dose-Dependent Effects of Zoledronic Acid on Human Periodontal Ligament Stem Cells: An In Vitro Pilot Study [PDF]
, 2020 Anna Di Vito +8 more
openalex +1 more source
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel [PDF]
, 2017 Bisphosphonates (BP) prevent, reduce, and delay cancer-related skeletal complications in patients, and have substantially decreased the prevalence of such events since their introduction.
Aapro, M. +18 more
core
L-MTP-PE and zoledronic acid combination in osteosarcoma: pre-clinical evidence of positive therapeutic combination for clinical transfer [PDF]
, 2016 Osteosarcoma, the most frequent malignant primary bone tumor in pediatric patients is characterized by osteolysis promoting tumor growth. Lung metastasis is the major bad prognosis factor of this disease.
Biteau, K. +7 more
core
Zoledronic acid in the management of metastatic bone disease
Therapeutics and Clinical Risk Management, 2008 Thomas J Polascik, Vladimir MouravievDuke Prostate Center and Division of Urologic Surgery, Duke University Medical Center, Durham, NC, USAAbstract: Many patients with advanced cancer experience decreased bone strength due to metastatic foci, underlying ...
Thomas J Polascik, Vladimir Mouraviev
doaj
4CPS-170 Evaluation of zoledronic acid in the treatment of bone diseases with high risk of fractures
, 2018 C Puivecino-Moreno +6 more
openalex +2 more sources
Zoledronic Acid for Periprosthetic Bone Mineral Density Changes in Patients With Osteoporosis After Hip Arthroplasty—An Updated Meta-Analysis of Six Randomized Controlled Trials [PDF]
, 2021 Yuan Liu +5 more
openalex +1 more source